Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting
暂无分享,去创建一个
[1] I. Ghiran,et al. Calreticulin Is at the Surface of Circulating Neutrophils and Uses CD59 as an Adaptor Molecule* , 2003, Journal of Biological Chemistry.
[2] G von Heijne,et al. Signal sequences. The limits of variation. , 1985, Journal of molecular biology.
[3] Paul Workman,et al. Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin. , 2007, Cancer research.
[4] Walter Kolch,et al. The molecular make-up of a tumour: proteomics in cancer research. , 2005, Clinical science.
[5] K. Tracey,et al. The cytokine activity of HMGB1 , 2005, Journal of leukocyte biology.
[6] L. Liotta,et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.
[7] P. Hains,et al. Proteome Analysis of Vinca Alkaloid Response and Resistance in Acute Lymphoblastic Leukemia Reveals Novel Cytoskeletal Alterations* , 2003, Journal of Biological Chemistry.
[8] K. Tracey,et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. , 2003, American journal of physiology. Cell physiology.
[9] H. Rauvala,et al. Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. , 1993, The Journal of biological chemistry.
[10] D. Mccormick. Sequence the Human Genome , 1986, Bio/Technology.
[11] M. Lotz,et al. Stage-Specific Secretion of HMGB1 in Cartilage Regulates Endochondral Ossification , 2007, Molecular and Cellular Biology.
[12] Bonnie F. Sloane,et al. Pericellular cathepsin B and malignant progression , 2003, Cancer and Metastasis Reviews.
[13] Hitoshi Takahashi,et al. Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[14] Thomas C. Südhof,et al. A Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60 , 2001, Science.
[15] Emma J. Blott,et al. Secretory lysosomes , 2002, Nature Reviews Molecular Cell Biology.
[16] R. Aebersold,et al. Mass spectrometry-based proteomics , 2003, Nature.
[17] L. Lum,et al. Evidence for a Role of a Tumor Necrosis Factor-α (TNF-α)-converting Enzyme-like Protease in Shedding of TRANCE, a TNF Family Member Involved in Osteoclastogenesis and Dendritic Cell Survival* , 1999, Journal of Biological Chemistry.
[18] Christopher M Overall,et al. Proteomics Discovery of Metalloproteinase Substrates in the Cellular Context by iTRAQ™ Labeling Reveals a Diverse MMP-2 Substrate Degradome*S , 2007, Molecular & Cellular Proteomics.
[19] Kai-Ping Chang,et al. Cancer cell‐secreted proteomes as a basis for searching potential tumor markers: Nasopharyngeal carcinoma as a model , 2005, Proteomics.
[20] P. Marin,et al. Proteomic Analysis of Astrocytic Secretion in the Mouse , 2003, Journal of Biological Chemistry.
[21] M. Stack,et al. Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[22] M. Mathews,et al. RNA binding and phosphorylation determine the intracellular distribution of nuclear factors 90 and 110. , 2005, Journal of molecular biology.
[23] W. Sadee,et al. A pharmacoproteomics study of the cancer cell line EKVX using capillary-LC/MS/MS. , 2006, Molecular pharmaceutics.
[24] A. Kungl,et al. A proteomic snapshot of the human heat shock protein 90 interactome , 2005, FEBS letters.
[25] Ron D. Appel,et al. ExPASy: the proteomics server for in-depth protein knowledge and analysis , 2003, Nucleic Acids Res..
[26] D. Altieri,et al. Regulation of Tumor Cell Mitochondrial Homeostasis by an Organelle-Specific Hsp90 Chaperone Network , 2007, Cell.
[27] H. Hoogsteden,et al. Proteomic analysis of exosomes secreted by human mesothelioma cells. , 2004, The American journal of pathology.
[28] Rainer Breitling,et al. What is Systems Biology? , 2010, Front. Physiology.
[29] W. Nickel. Unconventional Secretory Routes: Direct Protein Export Across the Plasma Membrane of Mammalian Cells , 2005, Traffic.
[30] D. Kwiatkowski,et al. Genomic organization and biosynthesis of secreted and cytoplasmic forms of gelsolin , 1988, The Journal of cell biology.
[31] Jeon-Soo Shin,et al. HMGB1 Is Phosphorylated by Classical Protein Kinase C and Is Secreted by a Calcium-Dependent Mechanism1 , 2009, The Journal of Immunology.
[32] Robert C. Wolpert,et al. A Review of the , 1985 .
[33] G. Kreitzer,et al. An Annexin 2 Phosphorylation Switch Mediates p11-dependent Translocation of Annexin 2 to the Cell Surface* , 2004, Journal of Biological Chemistry.
[34] J. Stow,et al. Nuclear Translocation of Cell‐Surface Receptors: Lessons from Fibroblast Growth Factor , 2005, Traffic.
[35] D. Solit,et al. Hsp90: the vulnerable chaperone. , 2004, Drug discovery today.
[36] H. Samaratunga,et al. Expression of the Disintegrin Metalloprotease, ADAM-10, in Prostate Cancer and Its Regulation by Dihydrotestosterone, Insulin-Like Growth Factor I, and Epidermal Growth Factor in the Prostate Cancer Cell Model LNCaP , 2004, Clinical Cancer Research.
[37] J. Reader,et al. The novel fragment of tyrosyl tRNA synthetase, mini‐ TyrRS, is secreted to induce an angiogenic response in endothelial cells , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[38] Christopher M Overall,et al. Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics. , 2009, Biochemistry.
[39] M. Goppelt‐Struebe,et al. Mechanical regulation of the Cyr61/CCN1 and CTGF/CCN2 proteins , 2006, The FEBS journal.
[40] Z. Chrzanowska-Lightowlers,et al. Annexin A2 binds to the localization signal in the 3′ untranslated region of c‐myc mRNA , 2005, The FEBS journal.
[41] Sunghoon Kim,et al. Functional expansion of aminoacyl-tRNA synthetases and their interacting factors: new perspectives on housekeepers. , 2005, Trends in biochemical sciences.
[42] Pier Paolo Pandolfi,et al. Changing venues for tumour suppression: balancing destruction and localization by monoubiquitylation , 2007, Nature Reviews Cancer.
[43] F L STONE,et al. TWO SIDES OF THE COIN. , 1963, Journal of medical education.
[44] A. Kungl,et al. A proteomic approach towards the Hsp90‐dependent ubiquitinylated proteome , 2007, Proteomics.
[45] K. Tracey,et al. HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.
[46] B. Eustace,et al. Extracellular Roles for the Molecular Chaperone, HSP90 , 2004, Cell cycle.
[47] D. Strickland,et al. Low density lipoprotein receptor–related protein is a calreticulin coreceptor that signals focal adhesion disassembly , 2003, The Journal of cell biology.
[48] Andrew Emili,et al. Proteomic methods for drug target discovery. , 2008, Current opinion in chemical biology.
[49] J. Piatigorsky,et al. Gene sharing in lens and cornea: facts and implications , 1998, Progress in Retinal and Eye Research.
[50] B. Fingleton,et al. Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.
[51] M. Selsted,et al. Purification and characterization of human T-lymphocyte-derived erythroid-potentiating activity. , 1984, The Journal of biological chemistry.
[52] S. Cheung,et al. Atypical localization of membrane type 1‐matrix metalloproteinase in the nucleus is associated with aggressive features of hepatocellular carcinoma , 2007, Molecular carcinogenesis.
[53] H. Rauvala,et al. Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. , 1991, The Journal of biological chemistry.
[54] R. Laskey,et al. Nuclear targeting sequences--a consensus? , 1991, Trends in biochemical sciences.
[55] H. Pollard,et al. A rise in nuclear calcium translocates annexins IV and V to the nuclear envelope , 1996, FEBS letters.
[56] A. Strongin,et al. Mislocalization and unconventional functions of cellular MMPs in cancer , 2006, Cancer and Metastasis Reviews.
[57] L. Lau,et al. The Angiogenic Factors Cyr61 and Connective Tissue Growth Factor Induce Adhesive Signaling in Primary Human Skin Fibroblasts* , 2001, The Journal of Biological Chemistry.
[58] Steven A Carr,et al. Identifying the proteins to which small-molecule probes and drugs bind in cells , 2009, Proceedings of the National Academy of Sciences.
[59] S. Shapiro,et al. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.
[60] J. Frydman,et al. The Hsp90 mosaic: a picture emerges , 2009, Nature Structural &Molecular Biology.
[61] K. Meyer-Siegler,et al. Cell cycle regulation of the glyceraldehyde-3-phosphate dehydrogenase/uracil DNA glycosylase gene in normal human cells. , 1993, Nucleic acids research.
[62] Takanori Aoki,et al. Matrix Metalloproteinases Cleave Connective Tissue Growth Factor and Reactivate Angiogenic Activity of Vascular Endothelial Growth Factor 165* , 2002, The Journal of Biological Chemistry.
[63] K Meyer-Siegler,et al. A human nuclear uracil DNA glycosylase is the 37-kDa subunit of glyceraldehyde-3-phosphate dehydrogenase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[64] M. Bianchi,et al. The nuclear protein HMGB1 is secreted by monocytes via a non‐classical, vesicle‐mediated secretory pathway , 2002, EMBO reports.
[65] M. Bogyo,et al. A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor. , 2004, Molecular cell.
[66] S. Munro,et al. A C-terminal signal prevents secretion of luminal ER proteins , 1987, Cell.
[67] M. Brown,et al. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[68] F. Jurnak,et al. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor , 2005, Molecular Cancer Therapeutics.
[69] Stephen M. Mount,et al. The genome sequence of Drosophila melanogaster. , 2000, Science.
[70] V. Devita,et al. Trials and tribulations , 2008, Nature Clinical Practice Oncology.
[71] P. Schimmel,et al. Two distinct cytokines released from a human aminoacyl-tRNA synthetase. , 1999, Science.
[72] L. Rothfield,et al. RNaseE and the other constituents of the RNA degradosome are components of the bacterial cytoskeleton , 2007, Proceedings of the National Academy of Sciences.
[73] L. Zolla,et al. A proteomic approach for evaluating the cell response to a novel histone deacetylase inhibitor in colon cancer cells. , 2008, Biochimica et biophysica acta.
[74] A. Fusco,et al. Retraction: Identification of new high mobility group A1 associated proteins , 2007, Proteomics.
[75] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[76] M. Bogyo,et al. Increased Expression and Activity of Nuclear Cathepsin L in Cancer Cells Suggests a Novel Mechanism of Cell Transformation , 2007, Molecular Cancer Research.
[77] S Subramani,et al. Import of peroxisomal matrix and membrane proteins. , 2000, Annual review of biochemistry.
[78] C. Overall,et al. Identification of Candidate Angiogenic Inhibitors Processed by Matrix Metalloproteinase 2 (MMP-2) in Cell-Based Proteomic Screens: Disruption of Vascular Endothelial Growth Factor (VEGF)/Heparin Affin Regulatory Peptide (Pleiotrophin) and VEGF/Connective Tissue Growth Factor Angiogenic Inhibitory Co , 2007, Molecular and Cellular Biology.
[79] F. Speleman,et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.
[80] F. Blasi,et al. Metalloproteases Cleave the Urokinase-Type Plasminogen Activator Receptor in the D1-D2 Linker Region and Expose Epitopes not Present in the intact Soluble Receptor , 2002, Thrombosis and Haemostasis.
[81] M. Vadas,et al. The cryptome: a subset of the proteome, comprising cryptic peptides with distinct bioactivities. , 2006, Drug discovery today.
[82] Raphael Kopan,et al. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain , 1998, Nature.
[83] D. Waisman,et al. Annexin A2 Is a Novel RNA-binding Protein , 2004, Journal of Biological Chemistry.
[84] C. López-Otín,et al. Protease degradomics: A new challenge for proteomics , 2002, Nature Reviews Molecular Cell Biology.
[85] V. Vasiliou,et al. ALDH3A1: a corneal crystallin with diverse functions. , 2007, Experimental eye research.
[86] S. Vandenberg,et al. Control of the nuclear-cytoplasmic partitioning of annexin II by a nuclear export signal and by p11 binding. , 2001, Journal of cell science.
[87] C. Overall,et al. Pharmacoproteomics of a Metalloproteinase Hydroxamate Inhibitor in Breast Cancer Cells: Dynamics of Membrane Type 1 Matrix Metalloproteinase-Mediated Membrane Protein Shedding , 2008, Molecular and Cellular Biology.
[88] Christopher M. Overall,et al. Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy , 2006, Nature Reviews Cancer.
[89] J. Tschopp,et al. The calcium-binding protein calreticulin is a major constituent of lytic granules in cytolytic T lymphocytes , 1993, The Journal of experimental medicine.
[90] G. Cagney,et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. , 2004, Blood.
[91] S. Lepreux,et al. Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis. , 2006, The American journal of pathology.
[92] H. Knull,et al. Association of glycolytic enzymes with the cytoskeleton. , 1992, Current topics in cellular regulation.
[93] Terence C W Poon,et al. Pharmacoproteomics study of cetuximab in nasopharyngeal carcinoma. , 2006, Journal of proteome research.
[94] Christopher M Overall,et al. Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome. , 2008, Molecular & cellular proteomics : MCP.
[95] J. Reynolds,et al. An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. , 1981, The Biochemical journal.
[96] Q. Gong,et al. Protective Effect of Antagonist of High‐mobility Group Box 1 on Lipopolysaccharide‐Induced Acute Lung Injury in Mice , 2009, Scandinavian journal of immunology.
[97] I. Gotoh,et al. Membrane‐type 1 matrix metalloproteinase cytoplasmic tail binding protein‐1 (MTCBP‐1) acts as an eukaryotic aci‐reductone dioxygenase (ARD) in the methionine salvage pathway , 2005, Genes to cells : devoted to molecular & cellular mechanisms.
[98] Bernhard Kuster,et al. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors , 2007, Nature Biotechnology.
[99] Wei Hu,et al. Proteomics in cancer research , 2002, International Journal of Gynecologic Cancer.
[100] M. Gurney,et al. Mouse glucose-6-phosphate isomerase and neuroleukin have identical 3′ sequences , 1988, Nature.
[101] K. Sakaguchi,et al. Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth , 1998, The Journal of experimental medicine.
[102] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[103] Z. Werb. ECM and Cell Surface Proteolysis: Regulating Cellular Ecology , 1997, Cell.
[104] Franck Molina,et al. Pharmacoproteomic approach to the study of drug mode of action, toxicity, and resistance: applications in diabetes and cancer , 2004, Fundamental & clinical pharmacology.
[105] H. Ariga,et al. A major cellular substrate for protein kinases, annexin II, is a DNA‐binding protein , 1994, FEBS letters.
[106] K. Tan,et al. Identification and characterization of mErk5-T, a novel Erk5/Bmk1 splice variant. , 2005, Gene.
[107] C. Overall,et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. , 2000, Science.
[108] Carlos López-Otín,et al. Strategies for MMP inhibition in cancer: innovations for the post-trial era , 2002, Nature Reviews Cancer.
[109] L. Pannell,et al. Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer. , 2007, Journal of proteome research.
[110] R. Schulz. Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches. , 2007, Annual review of pharmacology and toxicology.
[111] P. Ricciardi-Castagnoli,et al. Proteomic Analysis of Dendritic Cell-Derived Exosomes: A Secreted Subcellular Compartment Distinct from Apoptotic Vesicles1 , 2001, The Journal of Immunology.
[112] A. Strongin,et al. Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) Exhibits an Important Intracellular Cleavage Function and Causes Chromosome Instability* , 2005, Journal of Biological Chemistry.
[113] F. D’Acquisto,et al. Annexin 1 Cleavage in Activated Neutrophils , 2007, Journal of Biological Chemistry.
[114] L. Pearl,et al. A Two-Hybrid Screen of the Yeast Proteome for Hsp90 Interactors Uncovers a Novel Hsp90 Chaperone Requirement in the Activity of a Stress-Activated Mitogen-Activated Protein Kinase, Slt2p (Mpk1p) , 2005, Eukaryotic Cell.
[115] A. Jimeno,et al. Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer , 2008, Molecular Cancer Therapeutics.
[116] Andrew J. Ewald,et al. Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.
[117] D. Newton,et al. Proteomic Analysis Identifies Oxidative Stress Induction by Adaphostin , 2007, Clinical Cancer Research.
[118] Y. Naot,et al. Cloning of a Glucose Phosphate Isomerase/Neuroleukin-Like Sperm Antigen Involved in Sperm Agglutination1 , 2000, Biology of reproduction.
[119] J. Vishwanatha,et al. Regulation of nucleo-cytoplasmic shuttling of human annexin A2—a proposed mechanism , 2007, Molecular and Cellular Biochemistry.
[120] Haichao Wang,et al. Therapeutic potential of HMGB1-targeting agents in sepsis , 2008, Expert Reviews in Molecular Medicine.
[121] K. Brand,et al. Purification and characterization of phosphohexose isomerase from human gastrointestinal carcinoma and its potential relationship to neuroleukin. , 1988, Cancer research.
[122] P. Schimmel,et al. A new gamma-interferon-inducible promoter and splice variants of an anti-angiogenic human tRNA synthetase. , 2004, Nucleic acids research.
[123] W. Coetzee,et al. The Glycolytic Enzymes, Glyceraldehyde-3-phosphate Dehydrogenase, Triose-phosphate Isomerase, and Pyruvate Kinase Are Components of the KATP Channel Macromolecular Complex and Regulate Its Function* , 2005, Journal of Biological Chemistry.
[124] Y. Minami,et al. Intracellular HMGB1 transactivates the human IL1B gene promoter through association with an Ets transcription factor PU.1 , 2007, European journal of haematology.
[125] William J. Ray,et al. A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain , 1999, Nature.
[126] S. Zucker,et al. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment , 2000, Oncogene.
[127] K. Tracey,et al. Extracellular role of HMGB1 in inflammation and sepsis , 2004, Journal of internal medicine.
[128] Liang Xie,et al. Cyclophilin A Is a Proinflammatory Cytokine that Activates Endothelial Cells , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[129] D. Solit,et al. Development and application of Hsp90 inhibitors. , 2008, Drug discovery today.
[130] Wei Li,et al. Extracellular heat shock protein‐90α: linking hypoxia to skin cell motility and wound healing , 2007, The EMBO journal.
[131] J. Wegiel,et al. Gelsolin inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils , 2000, Brain Research.
[132] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[133] L. Lund,et al. Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. , 1992, The Journal of biological chemistry.
[134] K. Harigaya,et al. Tissue inhibitor of metalloproteinases from human bone marrow stromal cell line KM 102 has erythroid‐potentiating activity, suggesting its possibly bifunctional role in the hematopoietic microenvironment , 1990, FEBS letters.
[135] H. Rauvala,et al. Neurite growth-promoting protein (amphoterin, p30) binds syndecan. , 1992, Experimental cell research.
[136] W. Deal,et al. Reversible dissociation of tetrameric rabbit muscle glyceraldehyde 3-phosphate dehydrogenase into dimers or monomers by adenosine triphosphate. , 1969, The Journal of biological chemistry.
[137] C. Rozanas,et al. Capabilities using 2-D DIGE in proteomics research : the new gold standard for 2-D gel electrophoresis. , 2008, Methods in molecular biology.
[138] S. Tatarano,et al. Nuclear translocation of ADAM‐10 contributes to the pathogenesis and progression of human prostate cancer , 2007, Cancer science.
[139] S. Werner,et al. Active Caspase-1 Is a Regulator of Unconventional Protein Secretion , 2008, Cell.
[140] Andrew Emili,et al. Navigating the Chaperone Network: An Integrative Map of Physical and Genetic Interactions Mediated by the Hsp90 Chaperone , 2005, Cell.
[141] M. Kelley,et al. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target. , 2007, Molecular aspects of medicine.
[142] K. Tracey,et al. HMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2 , 2006, Shock.
[143] Anindya Sinha,et al. Some like it hot . . . , 1992, Nature.
[144] Sunghoon Kim,et al. Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[145] V. Herzog,et al. Evidence for extracellularly acting cathepsins mediating thyroid hormone liberation in thyroid epithelial cells. , 1996, Endocrinology.
[146] R. Cardone,et al. The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis , 2005, Nature Reviews Cancer.
[147] U. Novak,et al. Efficient ADAM22 surface expression is mediated by phosphorylation-dependent interaction with 14-3-3 protein family members , 2006, Journal of Cell Science.
[148] J. Riordan,et al. Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins. , 1991, Biochemistry.
[149] Gary R. Grotendorst,et al. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. , 1996, The Journal of investigative dermatology.
[150] W. Holzgreve,et al. Neutrophil NETs: a novel contributor to preeclampsia-associated placental hypoxia? , 2007, Seminars in Immunopathology.
[151] K. Elenitoba-Johnson,et al. Proteome‐wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells , 2007, Proteomics.
[152] R. Kellner,et al. Annexin II is a major component of fusogenic endosomal vesicles , 1993, The Journal of cell biology.
[153] C. Overall,et al. Proteomic discovery of protease substrates. , 2007, Current opinion in chemical biology.
[154] B. Cauwe,et al. The Biochemical, Biological, and Pathological Kaleidoscope of Cell Surface Substrates Processed by Matrix Metalloproteinases , 2007, Critical reviews in biochemistry and molecular biology.
[155] J. Štokrová,et al. HMGB1 interacts with human topoisomerase IIα and stimulates its catalytic activity , 2007, Nucleic acids research.
[156] Xiaodan Yu,et al. Proteomic analysis identifies protein targets responsible for depsipeptide sensitivity in tumor cells. , 2008, Journal of proteome research.
[157] R. Kelly,et al. Protein translocation: Rehearsing the ABCs , 1996, Current Biology.
[158] B. Freeman,et al. The Hsp90 Molecular Chaperone Modulates Multiple Telomerase Activities , 2007, Molecular and Cellular Biology.
[159] M. Gurney,et al. Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons. , 1986, Science.
[160] M. Ahram,et al. A proteomic approach to characterize protein shedding , 2005, Proteomics.
[161] G. Manfioletti,et al. Interaction proteomics of the HMGA chromatin architectural factors , 2008, Proteomics.
[162] T. Omura,et al. Mitochondria-targeting sequence, a multi-role sorting sequence recognized at all steps of protein import into mitochondria. , 1998, Journal of biochemistry.
[163] T. Misteli,et al. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.
[164] David E. Misek,et al. Global Profiling of the Cell Surface Proteome of Cancer Cells Uncovers an Abundance of Proteins with Chaperone Function* , 2003, The Journal of Biological Chemistry.
[165] R. Black,et al. A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes , 1995, The Journal of experimental medicine.
[166] J. García,et al. Functional and quantitative proteomics using SILAC in cancer research , 2008 .
[167] T. Veenstra,et al. The Human Plasma Proteome , 2004, Molecular & Cellular Proteomics.
[168] P. Workman,et al. Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone , 2000, Oncogene.
[169] M. Takigawa,et al. Novel Transcription Factor-Like Function of Human Matrix Metalloproteinase 3 Regulating the CTGF/CCN2 Gene , 2008, Molecular and Cellular Biology.
[170] H. Erickson,et al. Extracellular annexin II. , 1997, The international journal of biochemistry & cell biology.
[171] Constance J Jeffery,et al. Multifunctional proteins: examples of gene sharing , 2003, Annals of medicine.
[172] L. Mao,et al. Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor , 2003, Proteomics.
[173] Sabine S. Lange,et al. High mobility group protein B1 enhances DNA repair and chromatin modification after DNA damage , 2008, Proceedings of the National Academy of Sciences.
[174] C. Overall,et al. Cytokine Substrates: MMP Regulation of Inflammatory Signaling Molecules , 2008 .
[175] E. Melloni,et al. 3 – Selective Pro-Inflammatory Activation of Astrocytes by High Mobility Group Box 1 Protein Signaling , 2010 .
[176] G. Feuerstein,et al. Identification and characterization of triosephosphate isomerase that specifically interacts with the integrin αIIb cytoplasmic domain , 2006 .
[177] J. Reynolds,et al. Purification of rabbit bone inhibitor of collagenase. , 1981, The Biochemical journal.
[178] Sarat Chandarlapaty,et al. SNX2112, a Synthetic Heat Shock Protein 90 Inhibitor, Has Potent Antitumor Activity against HER Kinase–Dependent Cancers , 2008, Clinical Cancer Research.
[179] J. Foidart,et al. Membrane associated proteases and their inhibitors in tumour angiogenesis , 2004, Journal of Clinical Pathology.
[180] O. Silvennoinen,et al. STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5. , 2004, Cytokine & growth factor reviews.
[181] Ruedi Aebersold,et al. Quantitative proteomics by stable isotope labeling and mass spectrometry. , 2007, Methods in molecular biology.
[182] C. Blobel,et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). , 2001, The Journal of biological chemistry.
[183] B. Fingleton. MMPs as therapeutic targets--still a viable option? , 2008, Seminars in cell & developmental biology.
[184] E. Mariman,et al. Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines , 2004, Cellular and Molecular Life Sciences CMLS.
[185] K. Elenitoba-Johnson,et al. Quantitative Proteomic and Transcriptional Analysis of the Response to the p38 Mitogen-activated Protein Kinase Inhibitor SB203580 in Transformed Follicular Lymphoma Cells*S , 2004, Molecular & Cellular Proteomics.
[186] L. Neckers,et al. Functional proteomic screens reveal an essential extracellular role for hsp90α in cancer cell invasiveness , 2004, Nature Cell Biology.
[187] Sunghoon Kim,et al. Aminoacyl-tRNA synthetase complexes: beyond translation , 2004, Journal of Cell Science.
[188] L. Matrisian,et al. Matrix metalloproteinases: they're not just for matrix anymore! , 2001, Current opinion in cell biology.
[189] L. Zolla. Proteomics studies reveal important information on small molecule therapeutics: a case study on plasma proteins , 2008, Drug Discovery Today.
[190] T. Shiomi,et al. Membrane-type 1 Matrix Metalloproteinase Cytoplasmic Tail-binding Protein-1 Is a New Member of the Cupin Superfamily , 2004, Journal of Biological Chemistry.
[191] M. Hollenberg,et al. Proteolytic processing of SDF-1α reveals a change in receptor specificity mediating HIV-associated neurodegeneration , 2006, Proceedings of the National Academy of Sciences.
[192] A. Singer,et al. The molecular chaperone calnexin is expressed on the surface of immature thymocytes in association with clonotype‐independent CD3 complexes. , 1995, The EMBO journal.
[193] T. Ideker,et al. A new approach to decoding life: systems biology. , 2001, Annual review of genomics and human genetics.
[194] M. Tomita,et al. Nuclear Export Signal Consensus Sequences Defined Using a Localization‐Based Yeast Selection System , 2008, Traffic.
[195] Philippe Amouyel,et al. Two‐dimensional maps and databases of the human macrophage proteome and secretome , 2004, Proteomics.
[196] Georg Schett,et al. Dickkopf-1 is a master regulator of joint remodeling , 2007, Nature Medicine.
[197] M. Moses,et al. Making the cut: protease-mediated regulation of angiogenesis. , 2006, Experimental cell research.
[198] M. Stack,et al. Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis. , 2008, Seminars in cell & developmental biology.
[199] A. Chiarugi,et al. Relevance of high-mobility group protein box 1 to neurodegeneration. , 2007, International review of neurobiology.
[200] R. Soldi,et al. Secretion without Golgi , 2008, Journal of cellular biochemistry.
[201] A. Ridley,et al. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. , 2002, Cancer research.
[202] C. Czupalla,et al. Proteomic Analysis of Lysosomal Acid Hydrolases Secreted by Osteoclasts , 2006, Molecular & Cellular Proteomics.
[203] J. Freyssinet,et al. Membrane microparticles: two sides of the coin. , 2005, Physiology.
[204] C. Overall,et al. Towards third generation matrix metalloproteinase inhibitors for cancer therapy , 2006, British Journal of Cancer.
[205] R. Dwek,et al. The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG‐1 metastasis markers and leads to the identification of DJ‐1 as a potential serum biomarker , 2006, International journal of cancer.
[206] C. López-Otín,et al. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice , 2003, Nature Genetics.
[207] A. M. Houghton,et al. Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases. , 2006, Cancer research.
[208] C. Röcken,et al. Ectopeptidases in tumour biology: a review. , 2006, Histology and histopathology.
[209] E. Abraham,et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. , 2006, American journal of physiology. Cell physiology.
[210] U. Banerji,et al. Heat Shock Protein 90 as a Drug Target: Some Like It Hot , 2009, Clinical Cancer Research.
[211] M. Manjili,et al. Comment on “Tumor Progression Can Occur despite the Induction of Very High Levels of Self/Tumor Antigen-Specific CD8+ T Cells in Patients with Melanoma” , 2006, The Journal of Immunology.
[212] M. Michalak,et al. The ins and outs of calreticulin: from the ER lumen to the extracellular space. , 2001, Trends in cell biology.
[213] Stephen R. Clark,et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood , 2007, Nature Medicine.
[214] G. Struhl,et al. Nuclear Access and Action of Notch In Vivo , 1998, Cell.
[215] L. Pearl,et al. A common conformationally coupled ATPase mechanism for yeast and human cytoplasmic HSP90s , 2009, The FEBS journal.
[216] C. Overall,et al. Protease proteomics: revealing protease in vivo functions using systems biology approaches. , 2008, Molecular aspects of medicine.
[217] A. Raz,et al. The role of autocrine motility factor in tumor and tumor microenvironment , 2007, Cancer and Metastasis Reviews.
[218] G. Raposo,et al. Exosomes: endosomal-derived vesicles shipping extracellular messages. , 2004, Current opinion in cell biology.
[219] K. Tracey,et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[220] K. Tracey,et al. High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes , 2000, The Journal of experimental medicine.
[221] U. Andersson,et al. High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease , 2008, Arthritis research & therapy.
[222] R. Aebersold,et al. Proteomics: the first decade and beyond , 2003, Nature Genetics.
[223] International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome , 2001, Nature.
[224] C. Overall. Dilating the degradome: matrix metalloproteinase 2 (MMP-2) cuts to the heart of the matter. , 2004, The Biochemical journal.
[225] Sascha Keller,et al. Exosomes: from biogenesis and secretion to biological function. , 2006, Immunology letters.
[226] B. Fingleton. MMP Inhibitor Clinical Trials – The Past, Present, and Future , 2008 .
[227] D. Thompson,et al. Application of proteomic technologies in the drug development process. , 2003, Toxicology letters.
[228] T. Kislinger,et al. Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases , 2000, Nature.
[229] Jean Y. J. Wang,et al. Exploiting the promiscuity of imatinib , 2009, Journal of biology.
[230] K. Sakaguchi,et al. Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. , 1999, Blood.
[231] H. Huttunen,et al. Regulation of cell migration by amphoterin. , 2000, Journal of cell science.
[232] T. Südhof,et al. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. , 2001, Science.
[233] M. Presta,et al. Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine1 , 2006, The Journal of Immunology.
[234] D. Edwards. The cancer degradome : proteases and cancer biology , 2008 .
[235] L. Pearl,et al. The Hsp90 molecular chaperone: an open and shut case for treatment. , 2008, The Biochemical journal.
[236] Philippe Amouyel,et al. The proteome and secretome of human arterial smooth muscle cells , 2005, Proteomics.
[237] M. Belghazi,et al. Human epididymal secretome and proteome , 2006, Molecular and Cellular Endocrinology.
[238] Jeon-Soo Shin,et al. Nucleocytoplasmic Shuttling of HMGB1 Is Regulated by Phosphorylation That Redirects It toward Secretion1 , 2006, The Journal of Immunology.
[239] T Shinozaki,et al. Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. , 1996, Cancer research.
[240] G. Goodwin,et al. Interactions of a purified non-histone chromosomal protein with DNA and histone. , 1974, European journal of biochemistry.
[241] P. Stephens,et al. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity , 1985, Nature.
[242] Frank A Witzmann,et al. Pharmacoproteomics in drug development , 2003, The Pharmacogenomics Journal.
[243] Y. Fujiwara,et al. Extracellular proteome of human hepatoma cell, HepG2 analyzed using two-dimensional liquid chromatography coupled with tandem mass spectrometry , 2007, Molecular and Cellular Biochemistry.
[244] R. Milo,et al. Dynamic Proteomics of Individual Cancer Cells in Response to a Drug , 2008, Science.
[245] O. Yizhar,et al. Nonconventional Trafficking of Ras Associated with Ras Signal Organization , 2006, Traffic.
[246] W. Pratt,et al. The Hsp90 Chaperone Machinery Regulates Signaling by Modulating Ligand Binding Clefts* , 2008, Journal of Biological Chemistry.
[247] S. Dower,et al. Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. , 1994, Journal of immunology.
[248] T. Rabilloud,et al. Toward a better analysis of secreted proteins: the example of the myeloid cells secretome , 2007, Proteomics.
[249] R. Cramer,et al. PIGOK: Linking protein identity to gene ontology and function. , 2006, Journal of Proteome Research.
[250] H. Lehrach,et al. A Human Protein-Protein Interaction Network: A Resource for Annotating the Proteome , 2005, Cell.
[251] E. Brown,et al. Molecular characterization and expression of the gene encoding human erythroid-potentiating activity , 1985, Nature.
[252] S. Normark,et al. Neutrophil extracellular traps: casting the NET over pathogenesis. , 2007, Current opinion in microbiology.
[253] Cam Patterson,et al. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. , 2007, The Journal of clinical investigation.